CORRESP Filing
CytoDyn Inc.
Date: Aug. 19, 2025 · CIK: 0001175680 · Accession: 0001558370-25-011667
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288970
Letter
August 19, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Alan Campbell Re: CytoDyn Inc. Registration Statement on Form S-3 File No. 333-288970 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-3 filed on July 25, 2025 (Registration No. 333-288970) (the “Registration Statement”) so that the Registration Statement shall become effective at 9 am Eastern Time on August 21, 2025, or as soon as possible thereafter. The Company also requests that its letter requesting effectiveness at 8 am submitted on August 18, 2025, be withdrawn. We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing. If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you. Very truly yours, /s/ Robert Hoffman Robert E. Hoffman Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm August 19, 2025 VIA EDGAR Office of Life Sciences Division of Corporation Finance United States Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Attention: Alan Campbell Re: CytoDyn Inc. Registration Statement on Form S-3 File No. 333-288970 Request for Acceleration Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, CytoDyn Inc. (the “Company”) hereby respectfully requests acceleration of the effectiveness of the Company’s Registration Statement on Form S-3 filed on July 25, 2025 (Registration No. 333-288970) (the “Registration Statement”) so that the Registration Statement shall become effective at 9 am Eastern Time on August 21, 2025, or as soon as possible thereafter. The Company also requests that its letter requesting effectiveness at 8 am submitted on August 18, 2025, be withdrawn. We would appreciate notification by telephone of the effective date of the Registration Statement and confirmation of such effectiveness in writing. If you have any questions about the foregoing request, please contact our counsel, Mary Ann Frantz of Miller Nash LLP at (503) 205-2552, or the undersigned at (360) 980-8524. Thank you. Very truly yours, /s/ Robert Hoffman Robert E. Hoffman Chief Financial Officer